TMEM64 and breast carcinoma: We constructed a novel 6-gene signature (SQSTM1, GDF9, LINC01125, PTGS2, GVINP1, and TMEM64) and used an XGBoost model to predict the metastatic status in breast cancer (AUC = 0.82).